Skip Header

1 - 25 of 34 results for author:"Lu S.H." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (16)

[Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].

Xu C., Liu Y.L., Huang J., He D.M., Hou Y.Y., Ji Y., Hou J., Lu S.H., Xu J.F., Hu Q. et al.

Zhonghua Bing Li Xue Za Zhi 41:667-670(2012) · Mapped (8)

Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.

Wu Y.C., Ling T.Y., Lu S.H., Kuo H.C., Ho H.N., Yeh S.D., Shen C.N., Huang Y.H.

Cancer Res. 72:4963-4973(2012) · Mapped (49)

CD72 gene expression in immune thrombocytopenia.

Zhou H., Qi A.P., Li H.Y., Ma L., Xu J.H., Xue F., Lu S.H., Zhao Q.J., Zhou Z.P., Yang R.C.

Platelets 23:638-644(2012) · Mapped (24)

The association between adult asthma and superoxide dismutase and catalase gene activity.

Yang L.L., Huang M.S., Huang C.C., Wang T.H., Lin M.C., Wu C.C., Wang C.C., Lu S.H., Yuan T.Y., Liao Y.H. et al.

Int. Arch. Allergy Immunol. 156:373-380(2011) · Mapped (15)

A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.

Li L.W., Li Y.Y., Li X.Y., Zhang C.P., Zhou Y., Lu S.H.

BMC Cancer 11:52-52(2011) · Mapped (5)

Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinoma.

Lu S.H., Chen Y.L., Shun C.T., Lai J.N., Peng S.Y., Lai P.L., Hsu H.C.

J. Gastroenterol. Hepatol. 26:90-97(2011) · Mapped (2)

Molecular cloning and characterization of a novel esophageal cancer related gene.

Cui Y., Bi M., Su T., Liu H., Lu S.H.

Int. J. Oncol. 37:1521-1528(2010) · Mapped (1)

Capacitation suppression by mouse seminal vesicle autoantigen involves a decrease in plasma membrane Ca2+-ATPase (PMCA)-mediated intracellular calcium.

Lu S.H., Yen Y.K., Ling T.Y., Cheng K.T., Shu J.A., Au H.K., Huang Y.H.

J. Cell. Biochem. 111:1188-1198(2010) · Mapped (9)

Kif18A is involved in human breast carcinogenesis.

Zhang C., Zhu C., Chen H., Li L., Guo L., Jiang W., Lu S.H.

Carcinogenesis 31:1676-1684(2010) · Mapped (3)

[IL-27 regulates the expression of Mac-1, fMLP-R and IL-1beta in human neutrophils through p38 MAPK and PI3K signal pathways].

Li J.P., Yang S.G., Dong C.L., Wu H., Jia H.R., Zhao Y.J., Wang T., Lu S.H., Ren Q., Zhao Q.J. et al.

Zhongguo Shi Yan Xue Ye Xue Za Zhi 18:391-395(2010) · Mapped (1)

Characterization of smooth muscle differentiation of purified human skeletal muscle-derived cells.

Lu S.H., Lin A.T., Chen K.K., Chiang H.S., Chang L.S.

J. Cell. Mol. Med. 15:587-592(2011) · Mapped (15)

ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration.

Cheng X., Lu S.H., Cui Y.

Cancer Lett. 290:87-95(2010) · Mapped (5)

ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway.

Cheng X., Shen Z., Yin L., Lu S.H., Cui Y.

J. Biol. Chem. 284:30897-30906(2009) · Mapped (4)

[Analysis on promoter CpG methylation and expression of HOXB4 gene in cord blood CD34(+) cells and peripheral blood mononuclear cells].

Zheng C.L., Guo Z.X., Han Z.C., Zhou Y.L., Lu S.H., Ren Q., Lu M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi 17:674-678(2009) · Mapped (1)

Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.

Li L.W., Yu X.Y., Yang Y., Zhang C.P., Guo L.P., Lu S.H.

Int. J. Cancer 125:1505-1513(2009) · Mapped (1)

Regulation of LH receptor and PGF2alpha receptor signaling by the regulator of G protein signaling 2 (RGS2) in human and mouse granulosa cells.

Wu Y.L., Chuang H.H., Kou Y.R., Lee T.S., Lu S.H., Huang Y.C., Nishi Y., Yanase T.

Chin J Physiol 51:282-291(2008) · Mapped (3)

Mapping the putative binding site for uPA protein in Esophageal Cancer-Related Gene 2 by heteronuclear NMR method.

Geng Y., Feng Y., Xie T., Dai Y., Wang J., Lu S.H.

Arch. Biochem. Biophys. 479:153-157(2008) · Mapped (8)

Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues.

Chen J., Guo L., Peiffer D.A., Zhou L., Chan O.T., Bibikova M., Wickham-Garcia E., Lu S.H., Zhan Q., Wang-Rodriguez J. et al.

Int. J. Cancer 122:2249-2254(2008) · UniProtKB (1)

Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.

Feng X.M., Liu N., Yang S.G., Hu L.Y., Chen X.L., Fang Z.H., Ren Q., Lu S.H., Liu B., Han Z.C.

Biochem. Biophys. Res. Commun. 367:553-559(2008) · Mapped (1)

ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.

Cheng X., Shen Z., Yang J., Lu S.H., Cui Y.

J. Biol. Chem. 283:5888-5898(2008) · Mapped (1)

[Expression and effect of neuropilin-1 in acute myeloid leukemic cells].

Lu L., Zhang L., Xiao Z.J., Lu S.H., Wang G.S., Yang R.C., Han Z.C.

Zhongguo Shi Yan Xue Ye Xue Za Zhi 15:1150-1155(2007) · Mapped (14)

[Role of antiapoptotic Bcl-X(L) in megakaryocyte differentiation and maturation].

Zhang L., Yang R.C., Lu S.H., Liu B., Ren H., Han Z.B., Han Z.C.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao 29:374-378(2007) · Mapped (2)

ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity.

Huang G., Hu Z., Li M., Cui Y., Li Y., Guo L., Jiang W., Lu S.H.

Carcinogenesis 28:2274-2281(2007) · Mapped (1)

ECRG1, a novel candidate of tumor suppressor gene in the esophageal carcinoma, triggers a senescent program in NIH3T3 cells.

Zhao N., Huang G., Guo L., Lu S.-H.

Exp. Biol. Med. 231:84-90(2006) · UniProtKB (1)

Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma.

Li Y., Zhang X., Huang G., Miao X., Guo L., Lin D., Lu S.-H.

Carcinogenesis 27:798-802(2006) · UniProtKB (1)

to top of page·

Page of 2 | Next »